Carbon nanotubes (CNTs) are fibrous carbon-based nanomaterials with a potential to cause carcinogenesis in humans. Alterations in DNA methylation on cytosine-phosphate-guanidine (CpG) sites are potential markers of exposure-induced carcinogenesis. This study examined cytotoxicity, genotoxicity and DNA methylation alterations on human monocytic cells (THP-1) after incubation with single-walled CNTs (SWCNTs) and multi-walled CNTs (MWCNTs). Higher cytotoxicity and genotoxicity were observed after incubation with SWCNTs than incubation with MWCNTs. At the selected concentrations (25 and 100 µg/ml), DNA methylation alterations were studied. Liquid chromatography-mass spectrometry (LC-MS/MS) was used to assess global DNA methylation, and Illumina 450K microarrays were used to assess methylation of single CpG sites. Next, we assessed gene promoter-specific methylation levels. We observed no global methylation or hydroxymethylation alterations, but on gene-specific level, distinct clustering of CNT-treated samples were noted. Collectively, CNTs induced gene promoter-specific altered methylation and those 1127 different genes were identified to be hypomethylated. Differentially methylated genes were involved in several signalling cascade pathways, vascular endothelial growth factor and platelet activation pathways. Moreover, possible contribution of the epigenetic alterations to monocyte differentiation and mixed M1/M2 macrophage polarisation were discussed.
Introduction
Carbon nanotubes (CNTs) can be defined as fibrous carbon-based nanomaterials with a large aspect ratio and a size in two dimensions <100 nm. CNTs have unique mechanical, electrical and biological properties that are already exploited in applications (1) . Although CNTs can be manufactured in different length, surface and diameter, they are mainly discriminated into two types depending on the number of graphene layers in their structure: multi-walled CNTs (MWCNTs) that are 2-100 nm in diameter with multiple layers of graphene and single-walled CNTs (SWCNTs) that are 2 nm in diameter with a single layer of graphene. Physico-chemical aspects are important determinants of the toxicity of nanomaterial such as small size, thereby increasing surface area, surface structure, surface reactivity and (fibre) shape (2) . Their fibre structure, high tensile strength and bio-durability are somewhat similar to asbestos and might pose a significant health risk.
Numerous animal studies already reported adverse effects of MWCNTs and SWCNTs, including inflammation and fibrosis (3) (4) (5) (6) (7) (8) . In rodents, adenocarcinoma and mesothelioma were induced after MWCNT exposure (9, 10) . MWCNT-7 was identified as 'possibly carcinogenic to humans (IARC Group 2B)' (11) . A recent epidemiological study identified fibrosis biomarkers in the blood of people exposed to MWCNTs (12) . Increased production of pro-inflammatory genes such as interleukin 1β (IL-1β) and tumour necrosis factor α (TNF-α), increased reactive oxygen species (ROS) levels, nuclear factor κB (NF-κB) signalling and increase in TGF-β and platelet-derived growth factor were linked to fibrosis formation after exposure to CNTs (13) (14) (15) (16) .
Inhaled CNTs, reaching into the alveolar spaces, encounter with the monocytes/macrophages that will try to engulf CNTs to clear them from the lung, leading to activation the host defence by cytokine and chemokine production. Macrophages are plastic and can polarise to distinct phenotypes, adopting an M1 or M2 phenotype, activated by T helper 1 (Th1) or Th2 cytokines, respectively (17) . M1 macrophages are associated with host defence typically recognised by cytokines, i.e. TNF, interferon gamma (IFN-γ) genes, IL-1, IL-12, NF-κB signalling and ROS. M2 macrophages are not only associated with the tissue repair but also tumour growth and angiogenesis that supports the disease progression (18) . This type of macrophages typically express vascular endothelial growth factor (VEGF) and matrix metalloproteinase 9, IL-4, IL-13, IL-10, transforming growth factor (TGF-β) and insulin-like growth factor. Studies of immune response (specifically M2-like) after CNT exposure showed that inhaled MWCNTs result in immune suppression (decreased T-cell proliferation) by activation of IL-10 and TGF-β (19, 20) . Pulmonary exposure to SWCNTs also revealed immune suppression in dendritic cells (21) . A mixed M1/M2-like macrophage status was shown after exposure to MWCNTs by recruiting naive macrophages and induction of angiogenesis genes (VEGFA) in mouse macrophage cell line (22) .
Changes at the level of gene regulation (epigenetic changes) might determine the fate of the macrophage polarisation shift (23, 24) . Epigenetics are generally defined as 'the study of changes in gene function that are mitotically and/or meiotically heritable and that do not entail a change in DNA sequence' (25, 26) . A well-established epigenetic marker, DNA methylation, occurs typically on cytosine-phosphate-guanidine (CpG) sites of genes, controlled by DNA methyl transferase enzymes [DNA [cytosine-5]-methyltransferase 1 (DNMT1), DNMT3A/B]. CpG sites were scattered all around the genome, but they are densely populated on gene promoter regions, creating CpG islands. Hypomethylation on single CpG sites or CpG islands is often associated with upregulated gene expression, and hypermethylation is often associated with downregulated expression. DNA methylation alterations on the CpG sites within the gene body are also known to associate with the cancer-causing mutations (27) . In tumour tissue, global hypomethylation (mainly in non-coding regions of the DNA) usually coincides with gene-specific hypermethylation or hypomethylation, and global DNA demethylation results in genomic instability (28, 29) .
Here, we used high-throughput DNA methylation microarray (Illumina 450K) to understand the epigenetic regulation of immuneor cancer-related alterations in monocytes (THP-1 cells) incubated with MWCNTs and SWCNTs.
Materials and methods

Cell cultures
Human monocytes (THP-1) cells were used in order to determine first immune response after exposure to CNT in vitro. THP-1 cells were derived from leukaemia patients which were kindly provided by Dr Gruenert (University of California, San Francisco) and cultured in RPMI 1640 supplemented with 10% fetal bovine serum (FBS), 100 U/ml penicillin, 2 mM l-glutamine and 2.5 µg/ml fungizone in T25 cell vials at 37°C in a 100% humidified air containing 5% CO 2 . The culture was changed every 2 or 3 days until cells were confluent (7 days). Afterwards, 2.5 × 10 3 cells were subcultured in another flask. To avoid the effect of cell age on epigenetic results, cells at the same passage (passage number 4) were used for experiments.
Materials and exposure conditions
Standard reference materials of CNTs were obtained. MWCNTs were provided by the European Commission Joint Research Centre (JRC-NM400) and were fully characterised; details can be found at https://ec.europa.eu/jrc/sites/default/files/mwcnt-online.pdf (30) . SWCNTs were purchased from the US National Institute of Standards and Technology (NIST-SRM2483) and were fully characterised; details can be found at http://www.nist.gov/tpo/upload/ JeffeyFagan.pdf (31) . The material characteristics were verified by transmission electron microscopy (JEOL 1200-EX II). In brief, 5 µl CNT dispersion was added to copper grids with 200 hexagonal mesh (FF200H-Cu-50). When grids were dry, imaging was performed.
The standard CNT suspension protocol from the European Union project Engineered Nanoparticle Risk Assessment (ENPRA) was used (32) . In brief, CNTs were measured under high-efficiency particulate air-filtered laminar flow and diluted in sterile Baxter water containing 2% FBS to obtain 2.56 µg/ml CNTs. The stock solution was sonicated for 16 min. The intermediate solutions were prepared and then diluted 1/10 in serum-free cell medium. An amount of 0.2% FBS in final CNT concentrations was obtained.
Exposure concentrations of CNTs were chosen as 25 and 100 µg/ ml. In those concentrations, MWCNTs are noted to be non-cytotoxic and non-genotoxic, whereas increased toxicity was observed by SWCNTs.
Cytotoxicity by WST-1 and LDH assays
Cytotoxicity of CNT in the THP-1 cells was assessed by both WST-1 and LDH assays. The cells were exposed to 4, 8, 16, 32, 64 and 128 µg/ml of MWCNT and SWCNT for 24 h. Untreated cells were used as negative controls.
In WST-1 assay, the optical density was measured at 450 nm in a multi-well plate reader (BIORAD, Model680XR microplate reader). The relative viability was calculated against the negative controls (untreated cells) and demonstrated in percentage.
In LDH assay, the absorbance was measured by spectrophotometer at 340 nm for 3 min with 15 s interval. Velocity was calculated according to the standard curve. Finally, the cell viability was calculated according to the formulae: %Viability slope of lysate slope of lysate slope of leaka = + g ge 1
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DNA damage by alkaline comet assay
The cells were exposed to 25 and 100 µg/ml of MWCNT and SWCNT for 3 h and 24 h. Then, DNA strand breaks were analysed with Trevigen CometAssay kit according to the provided protocol. The DNA damage was examined under Olympus fluorescence microscope at a ×10 magnification. One hundred cells per batch in medians of three independent assays were analysed using CaspLab 1.2.3beta2 software (downloaded from http://www.casplab.com). Tail DNA (%) were measured as an indicator of DNA damage.
Micronuclei formation
OECD guidelines for in vitro mammalian micronucleus test was followed for micronucleus assay (33) . The test was conducted in two different protocol with and without cytochalasin B (Cyt B) postincubation (34) .
After 24 h of CNT incubation, the cells were waited for (36 h equals to 1.5 doubling time) with or without CytB in the cell medium. Then, 7.5 × 10 3 cells were immobilised on microscope slides using CytoSpin (Shandon, Cytospin 3). Micronuclei in mononucleated cells were counted in the experiment without CytB incubation. Micronuclei in binucleated cells were counted in the experiment with CytB post-incubation.
Three independent experiments with two biological replicates were performed. Two thousand cells were counted for each experiment. The results were shown in micronuclei cells per 1000 cells in average.
Non-gene-specific (global) DNA methylation by LC-MS/MS
An establish method was used to measure cytosine methylation in the DNA (35) . In brief, after cells were incubated with 25 and 100 µg/ml MWCNTs and SWCNTs, they were centrifuged at 1400 rpm for 5 min to remove supernatants and isolate cell pellets. The DNA was extracted using the QIAGEN DNA/RNA extraction mini kit and protocol. A positive control was the DNA demethylating agent Decitabine (1 µM). DNA quantification and quantity was checked by Nanodrop spectrometry (Thermo Scientific, 2000c).
A validated protocol for non-gene-specific (global) DNA methylation and hydroxymethylation analysis involved the use of liquid chromatography-mass spectrometry (LC-MS/MS) (35) . In brief, 1 µg DNA was spiked with internal standard mixture (labelled deoxycytodine) in each sample. Then, DNA was hydrolysed to individual deoxyribonucleosides by enzymatic reaction with 10 µl digestion mixture (phosphodiesteraseI, alkaline phosphatase and benzonase nuclease in Tris-HCl buffer) at 37°C, overnight before LC-MS/MS. Direct light was avoided during the protocol to avoid deamination of compounds.
DNA methylation array by Illumina450K and bioinformatics analysis
To detect CpG site methylation, 200 ng DNA underwent bisulfite treatment with use of the EZ DNA mini kit and protocol (Zymo Research, Orange, CA). IIllumina Infinium HumanMethylation450 BeadChip Array was used to assess genome-wide CpG site-specific DNA methylation. The data from microarray assay were processed by using Bioconductor R packages (R Development Core Team 2010).
Initial quality check was performed with the Minfi package with the SWAN method used for type I and II probe normalization (36) . Data annotation and filtering involved the IMA package (37) . Differentially methylated CpGs were identified using the limma package (using linear modelling approach and empirical Bayes statistics) and batch effects were corrected (38) . Ensemble gene annotation 75 was used to identify differentially methylated CpG sites and gene promoter regions (2000 bp upstream to 500 bp downstream of the transcription start site). All single CpG sites and gene promoter regions were annotated to genes according to the Illumina database. Methylation values (β-values) for each CpG site and gene promoter region were converted to M-values for small-scale samples (39) with the following equation:
Each methylation value was compared with the control or vehicletreated samples. Decitabine was used as a positive control when aberrant hypomethylation was observed. The values of P were corrected by false discovery rate (FDR) (40) .
Cluster and heat map analysis
Genes were ranked from low to high by their FDR-corrected P value.
The most significant 500 genes were mapped on the heat map using z values. The mapping and the clustering based on similarity of methylation profiles for each sample involved use of the RPMM/R package (41).
Computational KEGG and GO analysis
Differentially methylated CpG sites and gene promoters were defined by FDR-corrected P < 0.05 and annotated to their corresponding genes. These genes were used for computational gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis with the use of DAVID 6.8 (updated in May 2016) and Illumine450K background genes and differentially methylated target genes (42, 43) . GO analysis identifies genes according to their enrichment in cell pathways, and KEGG analysis identifies enrichment of the function of genes in the KEGG database.
Functional analysis
Functional analysis was conducted using differentially methylated genes. Those genes were investigated in KEGG database (http:// www.genome.jp/kegg/tool/map_pathway1.html) for their involvement in KEGG pathways. Using diagrams of the signalling pathways as a base Figure 4 is generated in order to elucidate epigenetically altered genes and pathways. 
Statistical analysis
One-way analysis of variance, Dunnett's multiple comparison for cytotoxicity, micronucleus tests and analysis of the LC-MS/MS data were carried out for statistical analyses. Student's t-test for comet assay were performed for the genotoxicity analysis, using GraphPad Prism5. Statistical analysis of the microarray involved use of R (for details see 'DNA methylation array by Illumina450K and bioinformatics analysis' above). Differentially methylated genes were identified with FDR-corrected P < 0.05. All experiments involved three independent repeats. Data are represented as mean ± SD.
Results
Material characteristics
Material characteristics, provided by the suppliers (JRC and NIST) are presented in Table 1 . Transmission electron microscopic images shown in Figure 1 illustrates both CNT types present in bundles and individual rope-like structures.
Cytotoxicity and genotoxicity of CNT (dose assessment)
Exposure to MWCNTs did not induce cell death, and SWCNTs showed somewhat greater cytotoxic effects (up to 60% of cell viability; Figure 2A and B). A concentration of 25 µg/ml was selected as not cytotoxic and 100 µg/ml as low cytotoxic concentration. At these concentrations, DNA damage ( Figure 3A ) and micronuclei formation were investigated ( Figure 3B and C). MWCNTs induced a significant level of DNA damage only at 25 µg/ml after 24 h, whereas SWCNTs conferred a dose-dependent induction of DNA damage. Exposure to MWCNTs did not result in significant increase in the frequency of micronuclei, but SWCNTs at a concentration of 100 µg/ml induced a significant micronuclei formation in the absence of CytB.
Global DNA methylation and hydroxymethylation alterations LC-MS/MS was used to measure non-specific whole-DNA cytosine methylation and hydroxymethylation after 24 h of CNT incubation with THP-1 cells. CNT incubation did not induce significant alterations in CpG site methylation or hydroxymethylation ( Figure 4A and B). As a positive control, decitabine induced significant DNA hypomethylation. Relative cytotoxicity compared with non-exposed cells were investigated using WST-1 assay and LDH assay. The cytotoxicity results from both types of analyses were depicted after exposure to (A) MWCNT and (B) SWCNT. The significance were indicated as **P < 0.01 and ***P < 0.001. MWCNTs-exposed samples are represented in black colour and SWCNTs are represented in grey colour.
Gene-specific differential methylation induced by SWCNTs and MWCNTs
Illumina 450K microarray was used to assess methylation differences between CNT and non-CNT-treated controls (untreated and vehicle treated) in more than 485 000 CpG sites within the whole genome. Considering that DNA methylation alterations on gene promoter regions affect gene expression, we averaged DNA methylation level in each gene promoter region with 1500 bp as upstream and 500 bp as downstream of the transcription start site. Both CpG sites within the region of a gene and gene promoters were annotated to corresponding genes according to the Illumina database.
In order to visualize the methylation profile of CNT-treated samples, we used a heat map ( Figure 5) . Here, the 500 highest ranked genes, according to methylation change in gene promoter compared with non-CNT-treated controls, were selected. The heat map demonstrates the z values of each gene in each sample with colour changes from blue (hypomethylation) to yellow (hypermethylation). The clustering of the samples is indicated by cladograms. The results indicate distant clustering of MWCNT-exposed samples (by mainly hypomethylation) as compared to SWCNT and non-CNT-treated controls. SWCNT-exposed samples were also distinguished from non-CNT-treated samples but not as clearly as MWCNT-exposed samples.
To explore significantly differentially methylated genes-using FDR-corrected P < 0.05-the CNT-treated samples (per dose and per type of CNT) were compared with the control samples (unexposed and vehicle exposed). No changes were observed when each dose of CNTs were compared with the control samples. Similarly, no CNT-dependent changes (dose groups per CNT type were combined) were observed compared with the control samples. When the data are combined (all CNT vs. control samples), in order to increase the power, we have identified 1127 different genes hypomethylated only on gene promoter regions (supplementary Table 1 , available at Mutagenesis Online). No differences in single CpG sites were noted.
These data suggest that although methylation alterations by exposure to MWCNTs are more prominent than exposure to SWCNTs, they did not differ significantly at the tested conditions.
GO and KEGG analysis of differentially methylated genes
To identify the biological function of the 1127 differentially methylated genes, we used GO analysis of the biological process (using Illumina450K background). The GO analysis showed 15 significantly enriched GOs presented in Table 2 . We noted epigenetic alterations in genes controlling gene expression, DNA-templated gene transcription, post-translational protein modification and chromatin organisation. The results also revealed significant methylation alterations in genes involved in blood coagulation, platelet activation and VEGF signalling (a known regulator of angiogenesis that is altered in cancer).
KEGG pathway analysis of differentially methylated genes revealed 119 significantly enriched KEGG pathways. The most significantly enriched pathways were presented in Table 3 . These enriched pathways indicated deregulation in cell signalling (i.e. PI3K-AKT, Rap1, Ras, MAPK, insulin, AMPK, cAMP, oestrogen, oxytocin and neurotrophin signalling as well as adrenergic signalling in cardiomyocytes and signalling pathways in regulating pluripotency of stem cells) and cancer pathways [i.e. cancer pathways, proteoglycans, microRNAs (miRNAs), transcriptional misregulation and choline metabolism]. Platelet activation and VEGF signalling pathways were significant on both GO and KEGG analyses. The analysis also revealed activated endocytosis mechanism with regulation of actin cytoskeleton and endocytosis pathways. 
Functional analysis of exposure to CNTs
Discussion
We exposed human monocytes (THP-1) to sub-cytotoxic and sub-genotoxic (for MWCNTs) and low-cytotoxic and genotoxic (for SWCNTs) concentrations of CNTs and analysed CpG methylation in their genome. We did not observe changes in global DNA methylation at 24 h of incubation, but we found, using GO and KEGG-analysis, clusters of differentially methylated genes in pathways linked to oncogenesis.
The results based on the heat map data reveal that MWCNTexposed cells involved more hypomethylated gene promoters compared with the SWCNT-exposed cells. Although they clustered distinctly, no significant differences between two CNT treatment groups were noted. In an attempt to postulate on the role of monocytes/macrophages at CNT exposure, we focused here on those genes with a role in M1/M2 state polarisation, angiogenesis and miRNA-associated mechanisms.
M1 macrophage activation is triggered by endogenous signals (e.g. IFN-γ and TNF-α) and/or exogenous signals (e.g. lipopolysaccharide), and M2 macrophage activation is triggered by IL-4, IL-13, IL-10 and immune complexes. IFN-γ and IL-4 activation is mediated by STAT1 and STAT6, respectively. The significant differentially methylated genes can be studied in view of 'M1/M2 polarisation'.
For M1 polarisation, STAT5A was hypomethylated in our study. STAT5 gene clusters are activated by JAK2 and subsequently activate downstream extracellular signal-regulated kinase (ERK) and Gene counts indicate the number of genes differentially methylated. P value by the Benjamini Hochberg method (Benjamini) as corrected P value. Platelet activation and VEGF signalling are in grey shade and boldface because this pathway overlapped with the KEGG analysis.
NF-κB and interferon regulatory factor 5. These alterations might induce M1 polarisation (44) .
In terms of M2-associated observations, hypomethylation of Janus kinase 3 (JAK3)-STAT6 genes in CNT-exposed THP-1 cells could be associated with STAT6 upregulation, in agreement with a recent observation in dendritic cell differentiation (45) . In cultured mouse monocytes, the activation of the JAK3/STAT6 complex-indicative of the M2 phenotype-stimulated renal fibrosis (46) . Moreover, miR-27 was previously found a regulator of M2 polarisation (47) . Although JAK3/STAT6 signalling is well characterised in TH-2 cell alterations, other factors such as NOTCH and VEGF might induce cell polarisation. We noted hypomethylation on VEGFA, NOTCH1 and NOTCH4, involved in angiogenesis and M2 cell polarisation.
For M1-or M2-associated polarisation, we looked in detail the PI3K-AKT and mTOR pathways, both previously associated with M1 and M2 polarisation (48) . Our analysis revealed in both genes and associated pathways alterations in methylation, possibly leading to the activation of PI3K-AKT signalling and downstream mTOR signalling. Our results are in agreement with Meng et al. (22) showing that CNT-exposed macrophages differentiate into M1/M2 mixed status, recruiting naive macrophages (as in the M1 state) and activating angiogenesis-related cytokines such as matrix metalloproteinase 9 and VEGF, with reduced release of pro-inflammatory cytokines (as in the M2 state).
'Angiogenesis' occurs in normal development and wound healing. However, for tumour initiation, angiogenic genes are exploited Gene counts indicate the number of genes differentially methylated. P value by the Benjamini Hochberg method (Benjamini) as corrected P value. Platelet activation and VEGF signalling are in grey shade and boldface because this pathway overlapped with the GO analysis.
to build new blood vessels around the tumour tissue and contribute to the tumour growth (49) . Our analysis showed differentially hypomethylated genes that play a role in angiogenesis pathways, including NOTCH1, NOTCH4, VEGFA, NOS3, WNT5B, PRKCZ, SH2D2A, SFRP1, FGFR1, TF, MAP2K2 and oncogenic AKT1. We also noted methylation alterations in genes involved in the regulation of transcription factors associated with angiogenesis, including NTRK, PML and HHEX.
Moreover, we observed hypomethylation of MEIS1, in the gene cluster of homeobox genes (HOXs). Importantly, HOXA4, HOXA7, HOXA10, HOXA11 and MEIS1 were found to be downregulated during 'monocyte (THP-1) differentiation' (50) . Also, activation of HOXD transcripts was found associated with MWCNT-induced carcinogenesis (51) . Therefore, DNA hypomethylation of MEIS1 might be important because altered HOX gene expression could contribute to the carcinogenic response.
'miRNA-associated mechanisms' are closely related to altered DNA methylation. Alterations on the gene promoter regions of small non-coding RNAs might interfere with crucial cell mechanisms, such as apoptosis, cell death, cell cycle, angiogenesis, by targeting genes with the sequence homology. We noted alterations in the following miRNA genes and the target genes: miR-27 and suppression of tumorigenicity 14,(ST14) miR-100, regulatory associated protein of MTOR complex 1 (RPTOR), miR-181 and miR-10b. These miRNAs and target genes are associated with carcinogenesis and metastasis (52) (53) (54) (55) (56) (57) (58) (59) . A recent study associated upregulation of miR-27-a (induced by IL-10 and ERK signalling) with monocyte M2 polarisation after exposure to alcohol.
Our GO and KEGG pathway analyses of differential CpG methylation of human monocytes (THP-1) to subtoxic concentrations of CNTs showed enrichment in genes involved in 'platelet activation'. Growing evidence suggests that circulating platelets in the blood have a role, besides injury and inflammation, in cancer metastasis (60, 61) . We noted hypomethylation of integrin subunit alpha 2b (antigen CD41; Figure 4 ). This receptor is known to induce platelet activation and aggregation via PI3K-AKT and Rap1 signalling pathways, both enriched on KEGG analyses (Table 2 ). This hypomethylation might lead to increased platelet aggregation and spreading. It is important to note that increased circulating monocyte-platelet binding was observed in some diseases including idiopathic pulmonary fibrosis (62) . Therefore, studying monocyte-platelet interactions can be a target for CNT-and/or asbestos-related diseases.
Our results might not be representative of different cell types because each cell type has unique epigenetic signatures and might respond to MWCNTs and SWCNTs differently. Our results also demonstrate a relatively acute (24-h) response to CNTs. These results may be altered substantially by human exposure featuring repetitive exposure year after year. As well, macrophage/monocytes in the different organs are derived from the same origin and adopt distinct genetic and epigenetic profiles because of their tissue-specific environment. Therefore, further in vivo or human studies are needed to elucidate the epigenetic toxicity of CNTs in monocytes.
Conclusion
In this study, we observed no global DNA methylation alterations with the tested CNTs after 24 h of incubation of THP-1 cells. Exposure to MWCNTs induced greater epigenetic alterations than SWCNTs according to heat map analysis. However, the two types of CNTs did not confer different FDR-corrected hypomethylation. Collectively enriched GO terms and KEGG pathways for differentially methylated genes exposed to CNTs revealed pathways involved in cancer initiation. Importantly, VEGF signalling and platelet activation was revealed by both analyses. Serial-activated signalling cascades might contribute to angiogenesis and a mixed M1/M2 macrophage polarisation by NOTCH1, NOTCH4, VEGFA, JAK3-STAT6, STAT5A, AKT1 genes, PI3K-AKT, angiogenesis and VEGF pathways, with a strong emphasis on M2 polarisation. Overall, our data contribute to a better insight into CNT-driven monocyte/macrophage activation and how CNT exposure may lead to an environment-tolerating carcinogenesis.
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